Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Rook

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Dermatologic Clinics|April 1, 1994
Retroviruses and cutaneous T-cell lymphomaS R Lessin, B R Vowels, A H Rook
Transplantation|October 1, 1984
Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipientsK M Ramsey, J Y Djeu, A H Rook
Archives of Dermatology|November 1, 1993
Molecular diagnosis of lymphocytic infiltrates of the skinJ M Weinberg, A H Rook, S R Lessin
The Journal of Investigative Dermatology|August 12, 1998
Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disordersF E Fox, Z Niu, A Tobia, et al.
The Journal of Allergy and Clinical Immunology|July 1, 1995
Expression of interleukin-4 and interleukin-5 mRNA in developing cutaneous late-phase reactionsB R Vowels, A H Rook, M Cassin, et al.
Journal of the American Academy of Dermatology|October 1, 1991
Extracorporeal photochemotherapy: a potentially useful treatment for scleromyxedemaM Berkson, G S Lazarus, M Uberti-Benz, et al.
The Journal of Investigative Dermatology|November 1, 1996
HTLV-I and CTCL: the link is missingS R Lessin, A H Rook, G Li, et al.
Journal of the American Academy of Dermatology|July 21, 2001
Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activityE K Yoo, M Cassin, S R Lessin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 13, 2001
Successful reversal of severe refractory cardiac allograft rejection by photopheresisM S Lehrer, A H Rook, J E Tomaszewski, et al.
Journal of Cutaneous Pathology|August 1, 1997
The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocationG Li, K E Salhany, A H Rook, et al.
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Dermatologic Clinics|April 1, 1994
Retroviruses and cutaneous T-cell lymphomaS R Lessin, B R Vowels, A H Rook
Transplantation|October 1, 1984
Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipientsK M Ramsey, J Y Djeu, A H Rook
Archives of Dermatology|November 1, 1993
Molecular diagnosis of lymphocytic infiltrates of the skinJ M Weinberg, A H Rook, S R Lessin
The Journal of Investigative Dermatology|August 12, 1998
Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disordersF E Fox, Z Niu, A Tobia, et al.
The Journal of Allergy and Clinical Immunology|July 1, 1995
Expression of interleukin-4 and interleukin-5 mRNA in developing cutaneous late-phase reactionsB R Vowels, A H Rook, M Cassin, et al.
Journal of the American Academy of Dermatology|October 1, 1991
Extracorporeal photochemotherapy: a potentially useful treatment for scleromyxedemaM Berkson, G S Lazarus, M Uberti-Benz, et al.
The Journal of Investigative Dermatology|November 1, 1996
HTLV-I and CTCL: the link is missingS R Lessin, A H Rook, G Li, et al.
Journal of the American Academy of Dermatology|July 21, 2001
Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activityE K Yoo, M Cassin, S R Lessin, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 13, 2001
Successful reversal of severe refractory cardiac allograft rejection by photopheresisM S Lehrer, A H Rook, J E Tomaszewski, et al.
Journal of Cutaneous Pathology|August 1, 1997
The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocationG Li, K E Salhany, A H Rook, et al.
Pageof 12